Profile of anemia in children with juvenile idiopathic arthritis
DOI:
https://doi.org/10.18203/2349-3291.ijcp20242337Keywords:
Anemia, Juvenile idiopathic arthritis, TreatmentAbstract
Background: Anemia is one of the commonest extra-articular manifestations or complications associated with juvenile idiopathic arthritis (JIA) and is generally seen to corelate with disease-duration and disease-activity. Aim of the study was to find out the prevalence of anemia, its etiological spectrum and severity in children suffering from JIA, to determine its correlation with disease-activity and disease-duration and assess the change in the status of anemia after initiating cause- specific treatment in addition to disease-specific treatment in a follow-up period of 3 months.
Methods: This prospective longitudinal observational study was conducted in a tertiary care teaching hospital from July to December 2022. Patients of JIA were recruited through purposive sampling stratified by disease activity based on juvenile arthritis disease activity score (JADAS) 27 score and anemia categorized by World Health Organization (WHO) criteria.
Results: A total of 64 children were included in the final analysis. Mean age of patients was 8.19 years (SD 2.34 years), male: female ratio being 1.2:1. 78.12% were anemic, with 59.37% being moderately anemic. Overall, anemia-of-chronic-disease (ACD) was the most (48%) prevalent type of anemia, followed by iron-deficiency-anemia (IDA) at 28%, followed by a combination of both IDA and ACD (12%). Remaining 12% was attributed to other causes of anemia. Mean-hemoglobin at 1st visit was found to decrease with increase in disease duration. Significant moderate linear negative correlation was found (r=-0.54) (p<0.001) between mean-hemoglobin-at-1st-visit and mean-disease-activity-at-1st-visit. Significant rise in hemoglobin level after initiation of cause-specific treatment with disease-specific treatment was also observed in this study.
Conclusions: Anemia associated with pediatric rheumatological conditions has significant negative impact on the disease process. Prompt diagnosis of anemia, denoting its type and severity, and thereby treating anemia alongside disease-specific treatment, significantly improves the patient outcome.
References
Barut K, Adrovic A, Sahin S, Kasapçopur Ö. Juvenile Idiopathic Arthritis. Balkan Med J. 2017;34:90-101.
Petty Re, Pedia D, Prieur Am, Southwood T, Baum J. Revision Of The Proposed Classification Criteria For Juvenile Idiopathic Arthritis: Durban, 1997. J Rheumatol. 1998;25:1991-4.
Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998;25:1991-4.
Castillo-Vilella M, Giménez N, Tandaipan JL, Quintana S, Modesto C. Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach. Pediatr Rheumatol. 2021;19:1-10.
Mattiello V, Schmugge M, Hengartner H, von der Weid N, Renella R, SPOG Pediatric Hematology Working Group. Diagnosis and management of iron deficiency in children with or without anemia: consensus recommendations of the SPOG Pediatric Hematology Working Group. Eur J Pediatr. 2020;179:527-45.
Cullis JO. Diagnosis and management of anaemia of chronic disease: current status. Br J Haematol. 2011;154:289-300.
International Conference on Nutrition (1992: Rome, Italy), World Health Organization. Nutrition Unit & Food and Agriculture Organization of the United Nations (1992). World Declaration and Plan of Action for Nutrition, Rome, December 1992. World Health Organization. Available at: https://iris.who.int/handle/10665/61051. Accessed on 12 May 2024.
World Health Organization. Iron deficiency anaemia: assessment, prevention and control, a guide for programme managers. 2001. Available at: https:// www.who.int/publications/m/item/iron-children-6to23--archived-iron-deficiency-anaemia-assess ment -prevention-and-control. Accessed on 12 May 2024.
Buaboonnam J, Charuvanij S. Hematologic involvement in Thai patients with juvenile idiopathic arthritis. Southeast Asian J Trop Med Public Health. 2017;48:141-50.
Singh S, Salarict M, Kumar L, Minz R, Datta U, Sehgal S. Clinico-immunological profile of juvenile rheumatoid arthritis at Chandigarh. Indian Pediatr. 1999;36:449-54.
Riaz R, Das S, Islam MI, Rahman SA. Assessment of anaemia in children with juvenile idiopathic arthritis and its relationship with disease activity and disease duration. Eur J Pharmaceut Med Res. 2020;7:570-4.
Seth V, Kabra SK, Semwal OP, Jain Y. Clinico-immunological profile in juvenile rheumatoid arthritis—an Indian experience. Indian J Pediatr. 1996;63:293-300.
Koerper MA, Stempel DA, Dallman PR. Anemia in patients with juvenile rheumatoid arthritis. J Pediatr. 1978;92:930-3.
